AleraCare and PURE Healthcare Announce Merger, Creating Unprecedented Opportunity for High-Quality Patient Care

AleraCare, a leading provider of infusion and specialty pharmacy services, and PURE Healthcare, a leading national medical group specializing in complex chronic conditions, have entered into a definitive merger agreement. The proposed merger creates an opportunity to provide high-quality patient care, improve clinical outcomes, and enhance the availability of infusion services, ultimately lowering the overall cost to the healthcare system.

Key Takeaways:

• AleraCare, founded in 2019, operates over 30 ambulatory infusion centers across the country, providing infusion services to high-need and medically complex populations.
• PURE Healthcare, founded in 2018, specializes in treating chronic and autoimmune conditions, offering innovative, high-quality care tailored to individual needs, and has expanded its flagship offering, Pure Infusion Suites, to 43 locations across 14 states.
• The transaction is expected to create an unprecedented opportunity to provide high-quality patient care, improve clinical outcomes, and enhance the availability of infusion services.
• AleraCare's core lines of business include ambulatory infusion centers, home infusion therapy, and specialty pharmacy, while PURE Healthcare offers infusion therapy at convenient, accessible locations, prioritizing patient comfort while significantly lowering the cost of infusion services.
• The merger is expected to close in the fourth quarter of 2025, subject to customary closing conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
• Holland & Knight is serving as legal counsel for AleraCare, while Kunzler Bean & Adamson is serving as legal counsel and Cantor Fitzgerald is acting as financial advisor for PURE Healthcare.

Statistics:

• AleraCare operates over 30 ambulatory infusion centers across the country.
• PURE Healthcare has expanded its flagship offering, Pure Infusion Suites, to 43 locations across 14 states.
• The infusion therapy market is expected to experience significant growth, driven by the increasing prevalence of chronic diseases and the need for high-quality, patient-centered care.

Sources:

• AleraCare news release (date not specified)
• PURE Healthcare website (dated 2018)
• Hart-Scott-Rodino Antitrust Improvements Act of 1976 (dated 1976)